Jaka jest cena za BillionToOne, Inc. (BLLN)

Cena za BillionToOne, Inc. (BLLN) wynosi $99.89

Jaka jest kapitalizacja rynkowa dla BillionToOne, Inc. (BLLN)

Kapitalizacja rynkowa dla BillionToOne, Inc. (BLLN) wynosi $4.59B

BillionToOne, Inc. (BLLN) Historia Cen

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.

Rok	Wydajność
2026 (TTM)	-3.30%
2025	0.00%

Rok

Wydajność

2026 (TTM)

-3.30%

2025

0.00%

Firma	Cena akcji	Zmiana 1r%	Kraj
Thermo Fisher Scientific Inc. TMO.US	$627.82	28.53%	US
Danaher Corporation DHR.US	$215.60	4.53%	US
WuXi AppTec Co., Ltd. 603259.SS	$23.08	70.53%	CN
Natera, Inc. NTRA.US	$334.93	102.12%	US
Agilent Technologies, Inc. A.US	$154.62	30.70%	US

Firma

Cena akcji

Zmiana 1r%

Kraj